{"nct_id":"NCT01539512","title":"A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)","status":"COMPLETED","status_verified_date":"2015-04","start_date":"2012-04","start_date_type":null,"primary_completion_date":"2013-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}